Phadungkiat Khamnoi

Mr. Phadungkiat Khamnoi

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
ITIngyin Shun Lae Thu
Ingyin Shun Lae Thu
Khajornsak TragoolpuaKhajornsak Tragoolpua
Khajornsak Tragoolpua
SISorasak Intorassot
Sorasak Intorassot
UWUsanee Wattananandkul
Usanee Wattananandkul
PKPhadungkiat Khamnoi
Phadungkiat Khamnoi
Chayada Sitthidet TharinjaroenChayada Sitthidet Tharinjaroen
Chayada Sitthidet Tharinjaroen
Streptococcus suis is an emerging zoonotic bacterium causing septicemia and meningitis in humans. Due to rapid disease progression, high mortality rate, and many underdiagnosed cases by time-consuming routine identification methods, alternative diagnostic testing is essential. Among 29 broadly accepted S. suis serotypes, serotypes 2 and 14 are high prevalent; however, many PCR assays showed an inability to differentiate serotype 2 from 1/2, and 1 from 14. In this study, we developed and validated a new multiplex PCR assay that facilitates the identification of only the 29 true serotypes of S. suis and simultaneously differentiates serotypes 1, 1/2, 2, and 14 within a single reaction. Importantly, the multiplex PCR could detect S. suis directly from positive hemocultures and CSF. The results revealed high sensitivity, specificity, and 100% accuracy with almost perfect agreement (κ = 1.0) compared to culture and serotyping methods. Direct detection enables a decrease in overall diagnosis time, rapid and efficient treatment, reduced fatality rates, and proficient disease control. This multiplex PCR offers a rapid, easy, and cost-effective method that can be applied in a routine laboratory. Furthermore, it is promising for developing point-of-care testing (POCT) for S. suis detection in the future.

16 November 2022 in Plants
Verified
Journal Article
Open access
PDF file
SSSiriwoot Sookkhee
Siriwoot Sookkhee
CSChoompone Sakonwasun
Choompone Sakonwasun
PMPitchaya Mungkornasawakul
Pitchaya Mungkornasawakul
PKPhadungkiat Khamnoi
Phadungkiat Khamnoi
NWNitwara Wikan
Nitwara Wikan
WNWutigri Nimlamool
Wutigri Nimlamool
The present study aimed to investigate the antibacterial activity of ethanolic Kaempferia parviflora extracts and the combined effects of the plant’s specific compounds with gentamicin against clinical strains of carbapenem-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. The minimal inhibitory concentrations (MIC) of gentamicin and Kaempferia parviflora extracts against the tested bacterial strains were determined by using broth microdilution. The combined effects of Kaempferia parviflora extract and gentamicin were investigated by using a checkerboard assay and expressed as a fractional inhibitory concentration index (FICI). Crude ethanolic extract of Kaempferia parviflora showed the lowest median values of MIC towards the tested isolates (n = 10) of these tested bacteria at doses of 64 µg/mL, compared to those of other Kaempferia extracts. Among the isolated compounds, only three compounds, namely 3,5,7-trimethoxyflavone, 3,5,7,3′4′-pentamethoxyflavone, and 5,7,4′-trimethoxyflavone, were identified by NMR structural analysis. According to their FICIs, the synergistic effects of gentamicin combined with 3,5,7,3′4′-pentamethoxyflavone were approximately 90%, 90%, and 80% of tested carbapenem-resistant Klebsiella pneumoniae (CRKP), Pseudomonas aeruginosa (CRPA), and Acinetobacter baumannii (CRAB), respectively. The present study concluded that 3,5,7,3′4′-pentamethoxyflavone extracted from Kaempferia parviflora potentiated the antibacterial action of gentamicin to combat bacterial resistance against the tested bacteria.

8 January 2025 in Foods
Verified
Journal Article
Open access
PDF file
SDSirikwan Dokuta
Sirikwan Dokuta
SYSumed Yadoung
Sumed Yadoung
SHSayamon Hongjaisee
Sayamon Hongjaisee
PKPhadungkiat Khamnoi
Phadungkiat Khamnoi
SMSirinya Manochomphu
Sirinya Manochomphu
SHsurat hongsibsong
surat hongsibsong
Antibiotic-resistant bacteria are usually found in food-producing animals worldwide. Ciprofloxacin, an antibiotic, can lead to antibiotic residues in food products, posing health risks to consumers and contributing to the development of antimicrobial resistance. Foodborne illnesses occur when adequate attention is not paid to food hygiene and safety, raising the potential for resistant bacteria to spread to humans through the food chain. This study aims to determine the presence of antibiotic-resistant organism contamination and ciprofloxacin residue in raw pork and chicken. Forty-three pork and 33 chicken meat samples were collected from fresh markets in Chiang Mai, Thailand. Antibiotic-resistant organisms were detected by microbial culture and identified by MALDITOF-MS. The antimicrobial sensitivity tests were used to confirm antibiotic resistance. The ciprofloxacin was detected by using an immunochromatographic-based test kit for screening. The results found Extended Spectrum β-lactamase (ESBL)-producing E. coli and K. pneumoniae were detected at 46.51% and 9.30% in pork and 69.70% and 6.06% in chicken meat samples, respectively. Moreover, ciprofloxacin residues were detected in nine samples (11.84%). Based on this study’s findings, the people who are involved in the food chain must be concerned about food safety and food hygiene.

30 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSiriwoot Sookkhee
Siriwoot Sookkhee
PKPhadungkiat Khamnoi
Phadungkiat Khamnoi
TSThanapat Sastraruji
Thanapat Sastraruji
SBSathian Boonkum
Sathian Boonkum
NWNitwara Wikan
Nitwara Wikan
WNWutigri Nimlamool
Wutigri Nimlamool
Vulvovaginal candidiasis (VVC) is the most common cause of vaginal discharge among women. The present study aimed to investigate the synergistic anticandidal effect of lactobacillus cultures supplemented with plant extracts. Among 600 isolates of lactic acid bacteria, 41 isolates exhibited inhibitory activity against Candida albicans ATCC10231. Six out of 41 cell-free supernatants demonstrated the most potent antibacterial and anticandidal activities. They also inhibited the clinical isolates of C. albicans, causing VVC and non-C. albicans. The synergistic effect between Lactobacillus crispatus 84/7 and Limosilactobacillus reuteri 89/4 was demonstrated by the lowest fractional inhibitory concentration index (FICI = 0.5). The synbiotic culture of bacterial combination, cultured with Jerusalem artichoke (H. tuberosus) extract, also exhibited the strongest inhibition against the tested C. albicans. Biofilm formation decreased after 12 h of incubation in the selected cell-free supernatants of this synbiotic culture. The anticandidal activity of crude extracts was lost after treatment with proteinase K and trypsin but not with heating conditions, suggesting that it may be a heat-stable substance. In conclusion, the combination of L. crispatus 84/7 and L. reuteri 89/4 with H. tuberosus may be a promising candidate for inhibiting Candida infection and biofilm formation, with the potential use as ingredients in vaginal biotherapeutic products.

9 March 2023 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
SKSutita Kumpangcum
Sutita Kumpangcum
PAPannita Anek
Pannita Anek
PKPhadungkiat Khamnoi
Phadungkiat Khamnoi
PPPeerada Prommeenate
Peerada Prommeenate
KPKulwadee Phannachet
Kulwadee Phannachet
The aim of this study was to identify and characterize multidrug resistance genes and the genetic contexts of integrons found in extensively drug resistant (XDR) Pseudomonas aeruginosa PA99 clinical isolate from Thailand. The sequencing of P. aeruginosa PA99 genomic DNA was done by using Pacific Biosciences RS II sequencing platform. The generated reads were de novo assembled by Canu version 1.4 and the annotation was performed using Prokka v1.12b. The complete genome sequence was subjected for identification of sequence type, serotype, integrons, and antimicrobial resistance genes by MLST 2.0, PAst 1.0, INTEGRALL, Resfinder 4.1, and CARD 3.2.5, respectively. Pseudomonas aeruginosa PA99 genome consisted of a 6,946,480-bp chromosomal DNA with 65.9% GC and belonged to ST964 and serotype O4. Twenty-one antimicrobial resistance genes conferring XDR phenotype were identified. Of special note were carbapenem resistance genes (blaIMP-1, blaPAO, blaOXA-21, and blaOXA-396) and colistin resistance gene basR with L71R mutation. Integron analysis revealed that P. aeruginosa PA99 harbored five class 1 integrons: two copies of In994 (blaIMP-1), an In1575 (aadB), and two novel integrons, In2083 (blaOXA-21 - aac(6')-Ib3 - aac(6')-Ib-cr - ere(A)1∆2 - dfrA1r) and In2084 (blaIMP-1 - aac(6')-Ib3 - aac(6')-Ib-cr). To the best of our knowledge, this is the first report of two novel class I integrons designated by INTEGRALL as In2083 and In2084 found in XDR-P. aeruginosa PA99 clinical isolate from Thailand. The characterization of genetic contexts of In2083 and In2084 provide the evidence of the assorting of resistance genes to evolve as novel integrons.

20 June 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
KKKawisara Krasaewes
Kawisara Krasaewes
SYSaowaluck Yasri
Saowaluck Yasri
PKPhadungkiat Khamnoi
Phadungkiat Khamnoi
RCRomanee Chaiwarith
Romanee Chaiwarith
Background:Staphylococcus aureus bloodstream infection (SA-BSI) causes morbidity and mortality. We established a management protocol for patients with SA-BSI aimed at improving quality of care and patient outcomes. Methods: A retrospective pre–post intervention study was conducted at Maharaj Nakorn Chiang Mai Hospital from 1 October 2019 to 30 September 2020 in the pre-intervention period and from 1 November 2020 to 31 October 2021 in the post-intervention period. Results: Of the 169 patients enrolled, 88 were in the pre-intervention and 81 were in the post-intervention periods. There were similar demographic characteristics between the two periods. In the post-intervention period, evaluations for metastatic infections were performed more frequently, e.g., echocardiography (70.5% vs. 91.4%, p = 0.001). The appropriateness of antibiotic prescription was higher in the post-intervention period (42% vs. 81.5%, p < 0.001). The factors associated with the appropriateness of antibiotic prescription were ID consultation (OR 15.5; 95% CI = 5.9–40.8, p < 0.001), being in the post-intervention period (OR 9.4; 95% CI: 3.5–25.1, p < 0.001), and thorough investigations for metastatic infection foci (OR 7.2; 95% CI 2.1–25.2, p = 0.002). However, the 90-day mortality was not different (34.1% and 27.2% in the pre- and post-intervention periods, respectively). The factors associated with mortality from the multivariate analysis were the presence of alteration of consciousness (OR 11.24; 95% CI: 3.96–31.92, p < 0.001), having a malignancy (OR 6.64; 95% CI: 1.83–24.00, p = 0.004), hypoalbuminemia (OR 5.23; 95% CI: 1.71–16.02, p = 0.004), and having a respiratory tract infection (OR 5.07; 95% CI: 1.53–16.84, p = 0.008). Source control was the only factor that reduced the risk of death (OR 0.08; 95% CI: 0.01–0.53, p = 0.009). Conclusion: One-third of patients died. Hospital-wide protocol implementation significantly improved the quality of care. However, the mortality rate did not decrease.